Lipocine (LPCN) EBT (2012 - 2025)
Lipocine's (LPCN) quarterly EBT came in at -$3.2 million in Q3 2025, down 43.63% YoY from -$5.7 million in Q3 2024, and down 44.48% on a QoQ basis from -$2.2 million in Q2 2025.
Lipocine (LPCN) EBT (2012 - 2025) Analysis & Trends
Lipocine (LPCN) has 14 years of EBT data on file, last reported at -$3.2 million in Q3 2025.
- Quarterly EBT fell 43.63% year-over-year to -$3.2 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$5.5 million (down 35.02% YoY) and the FY2024 annual result came in at $9033.0, up 100.06% from the prior year.
- EBT declined to -$3.2 million in Q3 2025, from -$2.2 million in the prior quarter.
- In the past five years, EBT ranged from a high of $12.6 million in Q4 2021 to a low of -$6.8 million in Q2 2021.
- A 5-year average of -$1.8 million and a median of -$2.6 million in 2022 frame the typical range for EBT.
- Annual changes were most pronounced in 2021 — EBT surged 379.83% — and 2023, when it sank 176.07%.
- Tracing LPCN's EBT over 5 years: stood at $12.6 million in 2021, then sank by 117.66% to -$2.2 million in 2022, then dropped by 2.34% to -$2.3 million in 2023, then surged by 178.11% to $1.8 million in 2024, then plunged by 278.82% to -$3.2 million in 2025.
- The last three EBT figures came in at -$3.2 million (Q3 2025), -$2.2 million (Q2 2025), and -$1.9 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Lipocine | 11.34 Mn | -12.57 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3.19 Mn |
| Jun 30, 2025 | -2.21 Mn |
| Mar 31, 2025 | -1.86 Mn |
| Dec 31, 2024 | 1.78 Mn |
| Sep 30, 2024 | -2.22 Mn |
| Jun 30, 2024 | -3.07 Mn |
| Mar 31, 2024 | 3.51 Mn |
| Dec 31, 2023 | -2.28 Mn |
| Sep 30, 2023 | -6.65 Mn |
| Jun 30, 2023 | -3.55 Mn |
| Mar 31, 2023 | -3.87 Mn |
| Dec 31, 2022 | -2.23 Mn |
| Sep 30, 2022 | -2.41 Mn |
| Jun 30, 2022 | -2.63 Mn |
| Mar 31, 2022 | -3.49 Mn |
| Dec 31, 2021 | 12.62 Mn |
| Sep 30, 2021 | -3.08 Mn |
| Jun 30, 2021 | -6.81 Mn |
| Mar 31, 2021 | -3.37 Mn |
| Dec 31, 2020 | -4.51 Mn |